JP2013530719A5 - - Google Patents

Download PDF

Info

Publication number
JP2013530719A5
JP2013530719A5 JP2013520127A JP2013520127A JP2013530719A5 JP 2013530719 A5 JP2013530719 A5 JP 2013530719A5 JP 2013520127 A JP2013520127 A JP 2013520127A JP 2013520127 A JP2013520127 A JP 2013520127A JP 2013530719 A5 JP2013530719 A5 JP 2013530719A5
Authority
JP
Japan
Prior art keywords
galactosyl
enzyme
amino acid
acid sequence
donor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013520127A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013530719A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/062355 external-priority patent/WO2012010597A1/en
Publication of JP2013530719A publication Critical patent/JP2013530719A/ja
Publication of JP2013530719A5 publication Critical patent/JP2013530719A5/ja
Pending legal-status Critical Current

Links

JP2013520127A 2010-07-19 2011-07-19 ガラクトオリゴ糖含有組成物およびそれを生産する方法 Pending JP2013530719A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36556010P 2010-07-19 2010-07-19
US61/365,560 2010-07-19
EP10169981 2010-07-19
EP10169981.7 2010-07-19
PCT/EP2011/062355 WO2012010597A1 (en) 2010-07-19 2011-07-19 Galacto-oligosaccharide-containing composition and a method of producing it

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016184955A Division JP2017018135A (ja) 2010-07-19 2016-09-22 ガラクトオリゴ糖含有組成物およびそれを生産する方法

Publications (2)

Publication Number Publication Date
JP2013530719A JP2013530719A (ja) 2013-08-01
JP2013530719A5 true JP2013530719A5 (cg-RX-API-DMAC10.html) 2014-08-28

Family

ID=43218466

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013520127A Pending JP2013530719A (ja) 2010-07-19 2011-07-19 ガラクトオリゴ糖含有組成物およびそれを生産する方法

Country Status (13)

Country Link
US (2) US20130189746A1 (cg-RX-API-DMAC10.html)
EP (1) EP2596113B1 (cg-RX-API-DMAC10.html)
JP (1) JP2013530719A (cg-RX-API-DMAC10.html)
KR (1) KR20130041953A (cg-RX-API-DMAC10.html)
CN (1) CN103080329B (cg-RX-API-DMAC10.html)
AR (1) AR082261A1 (cg-RX-API-DMAC10.html)
BR (1) BR112013001109A2 (cg-RX-API-DMAC10.html)
CA (1) CA2805997A1 (cg-RX-API-DMAC10.html)
DK (1) DK2596113T3 (cg-RX-API-DMAC10.html)
EA (1) EA201300150A1 (cg-RX-API-DMAC10.html)
MX (1) MX348325B (cg-RX-API-DMAC10.html)
NZ (1) NZ607149A (cg-RX-API-DMAC10.html)
WO (1) WO2012010597A1 (cg-RX-API-DMAC10.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2620506A1 (en) * 2012-01-25 2013-07-31 Arla Foods Amba Method of producing a galacto-oligosaccharide-containing composition
WO2013182686A1 (en) 2012-06-08 2013-12-12 Dupont Nutrition Biosciences Aps Polypeptides having transgalactosylating activity
EP2864492A4 (en) * 2012-06-22 2016-06-15 Glycom As MODIFIED GALACTO OLIGOSACCHARIDES
US11116235B2 (en) 2013-05-24 2021-09-14 General Mills, Inc. Food products with yogurt whey
AU2014363517B2 (en) 2013-12-11 2018-06-28 International N&H Denmark Aps A method for preparing a dairy product having a stable content of galacto-oligosaccharide(s)
KR101595014B1 (ko) 2014-02-21 2016-02-18 재단법인 임실치즈과학연구소 갈락토올리고당 생성 유산균주를 이용한 발효유의 제조방법
US20170339970A1 (en) * 2014-11-07 2017-11-30 Dupont Nutrition Biosciences Aps Method of generating a saccharide containing a galactose and a fructose moiety employing enzyme with transgalactosylating activity
CA2966718A1 (en) 2014-11-07 2016-05-12 Dupont Nutrition Biosciences Aps Recombinant host cell expressing beta-galactosidase and/or transgalactosylating activity deficient in mannanase, cellulase and pectinase
DK3607097T3 (da) 2017-04-07 2023-09-18 Dupont Nutrition Biosci Aps Bacillus-værtsceller, der danner beta-galactosidaser og lactaser i fravær af p-nitrobenzylesterase-sideaktivitet
GB201805577D0 (en) 2018-04-04 2018-05-16 Optibiotix Health Ltd Prebiotic compositions and methods of production thereof
AU2022354202A1 (en) 2021-09-30 2024-03-14 International N&H Denmark Aps Method for reducing sugar in food stuff
CN118695783A (zh) 2021-11-12 2024-09-24 凯里集团国际有限公司 生产乳制品的方法
WO2024206631A1 (en) 2023-03-29 2024-10-03 International N&H Denmark Aps Methods for modifying texture in foodstuff via preferably in situ produced alpha-glucan
WO2026015598A2 (en) 2024-07-11 2026-01-15 International N&H Denmark Aps Method to provide improved texture and stable sucrose levels in foodstuff with glucosyltransferase
WO2026102382A2 (en) 2024-11-11 2026-05-15 International N&H Denmark Aps Method for reducing sugar in foodstuff through conversion of fructose with epimerase
WO2026136198A1 (en) 2024-12-16 2026-06-25 International N&H Denmark Aps Soluble oligosaccharide syrup production

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6206801A (en) * 2000-05-26 2001-12-03 Arla Foods Amba A new enzyme isolated from a bifidobacterium
EP1205555A1 (de) * 2000-11-08 2002-05-15 Solvent Innovation GmbH Enzymkatalyse in Gegenwart ionischer Flüssigkeiten
PL1644482T5 (pl) * 2003-06-30 2015-05-29 Clasado Inc Nowa kompozycja galaktooligosacharydów i jej wytwarzanie
GB0522740D0 (en) * 2005-11-08 2005-12-14 Clasado Inc Process for the production of oligosaccharides

Similar Documents

Publication Publication Date Title
US12133899B2 (en) Coronavirus vaccine
JP7390349B2 (ja) 病的石灰化状態を治療するための組成物およびそれを使用する方法
EP3177723B1 (en) Aptamers for use against autoantibody-associated diseases
JP2015508291A5 (cg-RX-API-DMAC10.html)
JP2017510274A5 (cg-RX-API-DMAC10.html)
WO2010037836A3 (en) Cross-species-specific psmaxcd3 bispecific single chain antibody
MX344054B (es) Composicion de oligosacaridos y galactosacaridos de la leche para formula para lactantes que contiene la fraccion soluble de oligosacaridos presente en la leche y que tiene un bajo nivel de monosacaridos y un proceso para producir la composicion.
PH12013501927A1 (en) Nutritional compositions comprising alpha-hydroxyisocaproic acid
JP2014097057A5 (cg-RX-API-DMAC10.html)
RU2012105308A (ru) Композиции белка f rsv и способы их получения
WO2010092176A3 (en) Nontypable haemophilus influenzae antigens
JP2010077130A5 (cg-RX-API-DMAC10.html)
NZ571807A (en) Fat accumulation inhibitor
CN119947747A (zh) 流感病毒疫苗
JP2015188432A5 (cg-RX-API-DMAC10.html)
AU2017323868A1 (en) Lysine specific histone demethylase-1 inhibitors and uses therefor
Maccioni et al. Organization of the synthesis of glycolipid oligosaccharides in the Golgi complex
Madonna et al. Perspectives on sotatercept in pulmonary arterial hypertension
AU2021267932A1 (en) Methods for detection of pathogenic infections using red blood cell-containing patient samples
EP3936147A1 (en) Method for preparing influenza ha split vaccine
WO2026003578A1 (en) Multisubunit rsv, hmpv and hpiv vaccines and therapeutics
EP2091611A2 (fr) Nouveau médicament pour le traitement d'un cancer gastrique
TW201546129A (zh) 油水分離方法
JP2017533713A5 (cg-RX-API-DMAC10.html)
JP2016158578A5 (cg-RX-API-DMAC10.html)